Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
216
currently held
Exits tracked
96
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
HgCapital TrustadminNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution4 days agoNew Director · Appointment of ALI, Moynul as director · New director appointed · board evolution
adminTreble PeakcapitalShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal5 days agoShare Allotment · Statement of capital following allotment of shares · New shares issued · investment or fundraising signal
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminCompagnie Financière et de Participations RoullieradminBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board2 weeks agoBoard change · Management board member change:: ROULLIER Roxane, Marie-Thérèse · Change in the management board
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin267 companies matching · Page 1 of 6
Tubulis
Health for Life Capital II
FranceSector
Biotech
InvestorSeventure Partners
Entry
2020
Hold
6yr
Owners
6
AgoMab
Sabadell Asabys Health Innovation Investments
FranceSector
Biotech
InvestorAsabys Partners
Entry
2019
Hold
7yr
Owners
2
Exit
2026
to Public market (Nasdaq IPO ticker AGMB)
PathoQuest
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2021
Hold
5yr
Owners
2
Avalyn Pharma
BioDiscovery 5
FranceSector
Biotech
InvestorAndera Partners
Entry
2017
Hold
9yr
Exit
2026
to Public market (Nasdaq IPO ticker AVLN)
Precirix
HealthCap VII
FranceSector
Biotech
InvestorHealthCap
Entry
2018
Hold
8yr
Owners
2
Bilhi Genetics
CapHorn Invest 1
FranceSector
Biotech
InvestorCapHorn
Entry
2016
Hold
10yr
Exit
2026
Odyssey Therapeutics
Jeito II
FranceSector
Biotech
InvestorJeito Capital
Entry
2025
Hold
1yr
Exit
2026
ImCheck Therapeutics
Earlybird Health
FranceSector
Biotech
InvestorEarlybird Venture Capital
Entry
2017
Hold
8yr
Owners
4
Exit
2025
to Ipsen
Evommune
Oscar & Paul Venture Capital Fund I
FranceSector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2021
Hold
4yr
Owners
2
Exit
2025
to Public market (NYSE IPO ticker EVMN)
Imcheck
BioDiscovery 6
FranceSector
Biotech
InvestorAndera Partners
Entry
2020
Hold
5yr
Owners
2
Exit
2025
to Ipsen3.0x
Kalsiom
AFB Seed-Fund
FranceSector
Biotech
InvestorAdBio Partners
Entry
2020
Hold
6yr
Owners
2
Watchfrog
CapDecisif 3
FranceSector
Biotech
InvestorKarista
Entry
2008
Hold
17yr
Exit
2025
to Management
Medsenic
Cap Innov'Est 1
FranceSector
Biotech
InvestorCapital Grand Est
Entry
2016
Hold
10yr
Owners
2
Stilla Technologies
LBO France Venture
FranceSector
Biotech
InvestorLBO France
Entry
2018
Hold
7yr
Exit
2025
to Bio-Rad
Biobank
CAPZA 6 Private Debt
FranceSector
Biotech
InvestorCapza
Entry
2008
Hold
10yr
Owners
7
Amolyt Pharma
Sofinnova Crossover Fund I
FranceSector
Biotech
InvestorSofinnova Partners
Entry
2014
Hold
10yr
Owners
5
Exit
2024
to AstraZeneca4.0x
Clean Biologics
MED II
FranceSector
Biotech
InvestorARCHIMED
Entry
2018
Hold
6yr
Exit
2024
to MED Bio
Mablink Bioscience
Mérieux Innovation 1
FranceSector
Biotech
InvestorMerieux Equity Partners
Entry
2019
Hold
4yr
Owners
5
Exit
2024
to Eli Lilly
Fermentalg
ACI (Aquitaine Creation Investissement)
FranceSector
Biotech
InvestorAquiti Gestion
Entry
2010
Hold
13yr
Owners
4
DayTwo
Cathay Innovation Fund II
FranceSector
Biotech
InvestorCathay Capital
Entry
2017
Hold
7yr
Owners
2
EyeBio
Jeito I
FranceSector
Biotech
InvestorJeito Capital
Entry
2021
Hold
3yr
Owners
2
Exit
2024
to Merck
HI-Bio
Jeito I
FranceSector
Biotech
InvestorJeito Capital
Entry
2021
Hold
3yr
Exit
2024
to Biogen
InnoSkel
Jeito I
FranceSector
Biotech
InvestorJeito Capital
Entry
2020
Hold
4yr
Exit
2024
Mineralys Therapeutics
BioDiscovery 6
FranceSector
Biotech
InvestorAndera Partners
Entry
2022
Hold
4yr
Owners
2
Polyplus
Direct investment by Peugeot Invest
FranceSector
Biotech
InvestorPeugeot Invest
Entry
2016
Hold
7yr
Owners
2
Exit
2023
to Sartorius Stedim300.0x
Synthelis
CASRA Capital
FranceSector
Biotech
InvestorCrédit Agricole Alpes Développement
Entry
2013
Hold
10yr
Exit
2023
to Vincent Poher
Mablink
Capital Santé 2
FranceSector
Biotech
InvestorTurenne Groupe
Entry
2021
Hold
2yr
Owners
2
Exit
2023
to Eli Lilly
Calixar
Capital 2
FranceSector
Biotech
InvestorXAnge
Entry
2012
Hold
11yr
Exit
2023
to Eurofins Discovery
Neogene Therapeutics
Jeito I
FranceSector
Biotech
InvestorJeito Capital
Entry
2020
Hold
3yr
Exit
2023
to AstraZeneca
Phaxiam
Karista HealthTech Fund
FranceSector
Biotech
InvestorKarista
Entry
2018
Hold
5yr
Exit
2023
to Euronext Paris IPO + Erytech merger
HTL Biotechnology
Montagu VI
FranceSector
Biotech
InvestorMontagu Private Equity
Entry
2018
Hold
5yr
Owners
2
Transcure
Ledger Cathay Fund
FranceSector
Biotech
InvestorCathay Capital
Entry
2014
Hold
8yr
Owners
2
Lipofabrik
Re-Sources Capital
FranceSector
Biotech
InvestorRe-Sources Capital
Entry
2018
Hold
4yr
Exit
2022
to Éléphant Vert
Minka Therapeutics
CapDecisif 3
FranceSector
Biotech
InvestorKarista
Entry
2016
Hold
6yr
Exit
2022
to Management
IO Biotech
Kurma Biofund III
FranceSector
Biotech
InvestorEurazeo
Entry
2015
Hold
7yr
Owners
3
Groupe Grimaud
Crédit Mutuel Equity
FranceSector
Biotech
InvestorCrédit Mutuel Equity
Entry
2005
Hold
10yr
Owners
2
Exit
2021
to Crédit Mutuel Equity
PegaOne
BioDiscovery 5
FranceSector
Biotech
InvestorAndera Partners
Entry
2019
Hold
2yr
Exit
2021
to Centessa Pharmaceuticals
Afyren
Odyssee Venture Funds
FranceSector
Biotech
InvestorOdyssée Venture
Entry
2017
Hold
7yr
Owners
3
Polygon
Sorbonne Venture
FranceSector
Biotech
InvestorAloe Private Equity
Entry
2010
Hold
11yr
Owners
2
GAMUT Therapeutics
AFB Seed-Fund
FranceSector
Biotech
InvestorAdBio Partners
Entry
2020
Hold
1yr
Exit
2021
to SparingVision
MedDay Pharmaceuticals
BioDiscovery 4
FranceSector
Biotech
InvestorAndera Partners
Entry
2016
Hold
5yr
Exit
2021
Integragen
FPCI Entreprise & Croissance I
FranceSector
Biotech
InvestorGeneris Capital Partners
Entry
2010
Hold
10yr
Exit
2020
to OncoDNA
ABIONYX Pharma
Sofinnova Capital VI
FranceSector
Biotech
InvestorSofinnova Partners
Entry
2010
Hold
10yr
Exit
2020
Brainvectis
Erganeo
FranceSector
Biotech
InvestorErganeo
Entry
2015
Hold
5yr
Exit
2020
to Asklepios BioPharmaceutical
Cisbio
Abénex V
FranceSector
Biotech
InvestorAbénex
Entry
2016
Hold
3yr
Exit
2019
to PerkinElmer
PulseSight Therapeutics
CapDecisif 3
FranceSector
Biotech
InvestorKarista
Entry
2017
Hold
2yr
Exit
2019
to Management
Provepharm
MED II
FranceSector
Biotech
InvestorARCHIMED
Entry
2011
Hold
8yr
Owners
2
Hybrigenics
Odyssee Venture Funds
FranceSector
Biotech
InvestorOdyssée Venture
Entry
2013
Hold
5yr
Exit
2018
Lysogene
Sofinnova Capital VIII
FranceSector
Biotech
InvestorSofinnova Partners
Entry
2015
Hold
3yr
Exit
2018
GenSight Biologics
Sofinnova Crossover Fund I
FranceSector
Biotech
InvestorSofinnova Partners
Entry
2012
Hold
4yr
Owners
3